News

Shareholders that lost money on Cerevel Therapeutics Holdings, Inc. (ABBV) should contact Levi & Korsinsky about pending Class Action - ABBV
NEW YORK, NY / ACCESS Newswire / April 16, 2025 / If you suffered a loss on your Cerevel Therapeutics Holdings, Inc. (NYSE:ABBV) investment and ...
Cyabra Announces Record 2024 Financial Performance, Doubling Revenue and Strengthening Gross Margins
Revenues for the year ended December 31, 2024, were approximately $4,155 thousand, reflecting an increase of 116% compared to $1,922 thousand for the year ended December 31, 2023. The growth in ...